Insiders Fennec Pharmaceuticals Inc. Toronto S.E.

Equities

FRX

CA31447P1009

Market Closed - Toronto S.E. Other stock markets 20:59:59 17/07/2024 BST			5-day change	1st Jan Change
9.1 ^CAD	-0.55%		+12.62%	-39.97%

07-02	MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris	MT
07-01	Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris	07-02	MT
Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down	07-01	MT
Fennec Pharmaceuticals Inc. Announces Executive Changes	07-01	CI
Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	04-23	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	04-19	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	04-17	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	04-05	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	04-03	MT
Fennec Pharmaceuticals Inc. Announces the Appointment of Adrian Haigh as Chief Operating Officer	03/08/23	CI
Insider Sell: Fennec Pharmaceuticals	30/06/23	MT
Insider Sell: Fennec Pharmaceuticals	30/12/22	MT
Fennec Pharmaceuticals Chief Commercial Officer Resigns	31/01/22	MT
Shubh Goel to Depart Fennec Pharmaceuticals Inc. as Chief Commercial Officer in Late February 2022	31/01/22	CI
Fennec Pharmaceuticals Inc Announces Launch of European Named Patient Programme for Sodium Thiosulfate for Pediatric Patients with Standard Risk Hepatoblastoma	30/05/17	CI
Fennec Pharmaceuticals Inc. Appoints Marco Brughera to the Board of Directors	11/08/16	CI
Fennec Pharmaceuticals Inc. Appoints Khalid Islam as Chairman of the Board of Directors	09/12/15	CI
Adherex Technologies Inc. has Changed its Name to Fennec Pharmaceuticals Inc	03/09/14	CI
Adherex Technologies Inc. Announces the Appointment of Khalid Islam and Adrian Haigh to its Board of Directors	28/04/14	CI
Adherex Technologies Inc. Announces Executive Changes	15/08/13	CI
Thomas Spector Resigns as Chief Scientific Officer of Adherex Technologies Inc	20/06/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Fennec Pharmaceuticals Inc. Toronto S.E.

Equities

FRX

CA31447P1009

Insiders

Filters